Pharmacoeconomic advantages of using intrauterine levonorgestrel containing Mirena system in conjunction with the transdermal estrogen containing drugs for the treatment of menopausal syndrome and contraception during the menopausal transition - PDF (Russian)


Copyright (c) 2016 Baeva N.G., Filyaeva Y.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies